Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
BRAIN Biotech AG researches, develops, produces, and markets enzymes, biocatalysts, microorganisms, and bioactive natural substances for chemical industries in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates in two segments, BioScience and BioIndustrial. It identifies and develops bioactive natural compounds, including sugar substitutes and taste modulators, and nature-based active...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks.
Target Price
The average target price of BNN.DE is 5.4 and suggests 130% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell